T-CELL-INDEPENDENT B-CELL RESPONSE TO SELF-MONOSIALOGANGLIOSIDES - PRIMARY RESPONSE MONOCLONAL-ANTIBODIES

Purified GM(1) and GM(2) gangliosides incorporated into liposomes were injected subcutaneously in BALB/c mice every 3-4 days after pretreatm ent of the animals with low-dose cyclophosphamide, Serum samples were collected at different intervals and tests by ELISA for the presence o f anti-ganglioside antibodies. Four doses (50 mu g each) were sufficie nt to raise a measurable primary type of response to GM(1), while nine doses were required to obtain measurable IgM antibody titers to GM(2) . Three monoclonal antibodies (MAbs) were generated by fusing splenocy tes with mouse myeloma cells. The specificity of MAbs was determined b y ELISA and HPTLC-immunostaining using a panel of purified glycolipids . The MAb designated E1 showed a high degree of specificity because it reacted only with N-acetyl GM(2). Monoclonal antibody A3 reacted pred ominantly with GM(2) and GM(1), but also reacted moderately with the G M(2) ganglioside. The epitope recognized by this MAb is suggested to b e the trisaccharide sequence GalNAc beta 1-4(NeuAc alpha 2-3)Gal. The third MAb (F6) reacted strongly with GM(1) but a weak reactivity was a lso observed with GD(1b) as well as with asialo-GM(1), indicating that the terminal tetrasaccharide Gal beta 1-3GalNAc beta 1-4(NeuAc alpha 2-3)Gal- structure is probably involved in antigenic recognition, Form alin-fixed and paraffin-embedded tissue sections were stained with the E1 and A3 MAbs, using the avidin-biotin complex (ABC) technique, Stro ng immunoreactivity for E1 appeared in the tumor cells of five primary lung carcinomas and in five malignant melanomas. No immunoreactivity was demonstrated in the parenchyma of a lung without malignancy, or in a metastasis from a colon carcinoma.